| 注册
首页|期刊导航|中国药业|含微生态制剂的四联疗法治疗初治失败的幽门螺杆菌感染31例

含微生态制剂的四联疗法治疗初治失败的幽门螺杆菌感染31例

周刚 李之印 王仲略 沈慧琳

中国药业2011,Vol.20Issue(9):58-59,2.
中国药业2011,Vol.20Issue(9):58-59,2.

含微生态制剂的四联疗法治疗初治失败的幽门螺杆菌感染31例

Effect of Quadruple Therapy Containing Microecologics on Helicobacter Pylori Infection after First Treatment Failure in 31 Cases

周刚 1李之印 1王仲略 1沈慧琳1

作者信息

  • 1. 浙江省杭州市第二人民医院,浙江,杭州,310005
  • 折叠

摘要

Abstract

Objective To observe the effects and adverse reactions of quadruple therapy with microecologics supplementation on Helicobacter pylori(HP) infection after first treatment failure.Methods Sixty- two cases of HP eradication failure were divided into two groups randomly, group A treated with rabeprazole + furazolidone + amoxillin + colloidal bismuth pectin and group B with rabeprazole + furazolidone + amoxicillin + microecologics, the treatment course was 7 d in both groups.The eradication of HP was redetermined by the 14C- urea breath test in 4 weeks after treatment.Results The eradication rate was 79.31% in group A and 83.33% in group B respectively(P>0.05).The gastrointestinal adverse reactions in group B were fewer than those in group A( P < 0.05).Conclusion The quadruple therapy containing microecologics is effective in HP infection eradication after first treatment failure, furthermore, which may obviously reduce the adverse reactions in the treatment course.

关键词

微生态制剂/幽门螺杆菌/四联疗法

分类

医药卫生

引用本文复制引用

周刚,李之印,王仲略,沈慧琳..含微生态制剂的四联疗法治疗初治失败的幽门螺杆菌感染31例[J].中国药业,2011,20(9):58-59,2.

基金项目

浙江省自然科学基金项目,项目编号:Y0280675. ()

中国药业

OACSTPCD

1006-4931

访问量0
|
下载量0
段落导航相关论文